NanoXplore to Host a Webcast to Discuss Fourth Quarter and Year End Results on September 12, 2023

NanoXplore Inc. (" NanoXplore ") (TSX: GRA and OTCQX: NNXPF) is pleased to hold a webcast to discuss the results of its fourth quarter and the year ended JuneĀ 30, 2023, on Tuesday, September 12, 2023, at 8:30 a.m. Eastern Time. The financial results will be released on Monday September 11, 2023, after the market close.

Details of the Q4 Webcast

When : September 12, 2023, at 8:30 a.m. Eastern Time

Webcast : To listen to the live webcast, please join and register at:

https://edge.media-server.com/mmc/p/7j3xvu2s

or via our website under Events and Presentations in our Investors section at www.nanoxplore.ca .

A replay of the event will be available at the above webcast link or in the Investors section under Events and Presentations of the Company's website at www.nanoxplore.ca .

About NanoXplore Inc.

NanoXplore is a graphene company, a manufacturer and supplier of high-volume graphene powder for use in transportation and industrial markets. The Company provides standard and custom graphene-enhanced plastic and composite products to various customers in transportation, packaging, electronics, and other industrial sectors. NanoXplore is headquartered in Montreal, Quebec with manufacturing facilities across North America and Europe. Please visit www.nanoxplore.ca .

For further information, please contact:

Pedro Azevedo
Chief Financial Officer
Pedro.azevedo@nanoxplore.ca
Tel: +1Ā 438Ā 476Ā 1973


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

GRA:CC
The Conversation (0)
Satellos Bioscience Inc.

Satellos Bioscience Inc.

Satellos Bioscience Inc is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Its lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this... Keep Reading...
Vaxcyte Inc.

Vaxcyte Inc.

Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. Keep Reading...
G6 Materials

G6 Materials

OverviewG6 Materials Corp. (TSXV:GGG,OTCQB:GPHBF) provides high-tech graphene solutions for a variety of commercial, research and military applications at low costs. Through the company’s wholly-owned subsidiary, Graphene Laboratories Inc., G6 Materials currently offers over 100 graphene and... Keep Reading...
G6 Materials Corp Closes $1,001,000 Private Placement

G6 Materials Corp Closes $1,001,000 Private Placement

G6 Materials Corp. (TSXV:GGG) (OTC:GPHBF) (the ā€œCompanyā€ or ā€œG6ā€) is pleased to announce that it has closed a non-brokered private placement and issued 14,300,001 units at a price of $0.07 per unit to raise aggregate proceeds of $1,001,000.07. Each unit consists of one common share and one... Keep Reading...
G6 Materials Corp. Announces Upsize of Private Placement to Raise $1,001,000

G6 Materials Corp. Announces Upsize of Private Placement to Raise $1,001,000

G6 Materials Corp. (the ā€œCompanyā€ or ā€œG6ā€) (TSXV:GGG) (OTC:GPHBF) is pleased to announce its intention to increase the size of its previously announced non-brokered private placement from C$350,000 to $1,001,000. The Company will issue up to 14,300,000 Units for total gross proceeds of up to... Keep Reading...
G6 Materials Corp. Develops Disinfection Products to Fight the Spread of COVID-19

G6 Materials Corp. Develops Disinfection Products to Fight the Spread of COVID-19

G6 Materials Corp. (the ā€œCompanyā€ or ā€œG6ā€) (TSXV:GGG) (OTC:GPHBF) is pleased to provide an update from its Research & Development department. The outbreak of the COVID-19 has drastically altered the economic landscape, and G6 management is optimizing the business model to accommodate the new... Keep Reading...

Interactive Chart

Latest Press Releases

Related News